过去一年中添加的文章,按日期排序

[HTML][HTML] Clinical value of serum tumor markers in assessing the efficacy of neoadjuvant chemotherapy in advanced ovarian cancer: single-center prospective clinical …

J Huang, D Du, H Chen, D Luo, Q Wang, C Li… - Frontiers in …, 2024 - ncbi.nlm.nih.gov
25 天前 - … resistance, and accurately select patients suitable for NACT, this study utilizes
dynamic testing of NLR and tumor markers including CA125, CA199, CEA, CA153, and HE4

[HTML][HTML] 贝伐珠单抗联合TP 方案的新辅助化疗对晚期卵巢癌患者的临床效果分析

李园, 唐新华, 周云婷, 孙双双, 王黎明 - Advances in Clinical …, 2024 - hanspub.org
96 天前 - … clinical effect of neoadjuvant chemotherapy of bevacizumab … After treatment, the
clinical indicators of CA125, HE4 and … Conclusion: The neoadjuvant chemotherapy combined …

… in advanced-stage, high-grade serous ovarian cancer: Analysis of HE4 kinetics during NACT, predicting surgical outcome and recurrence in comparison to CA125

A AlSomairi, S Himayda, A Altelmesani, YJ Lee… - Gynecologic …, 2024 - Elsevier
186 天前 - CA-125 or HE4 levels during NACT and residual disease or recurrence. The
normalization of HE4 – but not CA-125 – … utility of HE4 changes during neoadjuvant chemotherapy

The efficacy of serum CA125 and HE4 as a prognostic marker for the germline BRCA-affected patients in high-grade serous carcinoma (1175)

YJ Lee, SM Hong, YJ Lee, JY Lee… - Gynecologic …, 2023 - gynecologiconcology-online.net
311 天前 - … received neoadjuvant chemotherapy with serial follow-up by serum CA-125 and
HE4 at a … the normalization of the serum CA-125 and HE4 levels after the second neoadjuvant

Role of Serum CA125 and HE4 in Predicting Optimal Cytoreduction in Advanced Epithelial Ovarian Cancer After Neoadjuvant Chemotherapy

P Poddar, S Patel, R Arora - Indian Journal of Gynecologic Oncology, 2023 - Springer
324 天前 - … Pre-chemotherapy and pre-IDS CA125, HE4 and CT response were used to calculate
… to determine the optimal threshold of HE4 levels and CA125 levels for predicting optimal …